Mangiferin Mitigates Lipopolysaccharide-Induced Lung Injury by Inhibiting NLRP3 Inflammasome Activation
Ning Li,* Rui Xiong,* Ruyuan He, Bohao Liu, Bo Wang, Qing Geng Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, People’s Republic of China*These authors contributed equally to this workCorrespondence: Bo Wang; Qing GengDepartment of Thoracic Surgery, Renm...
Guardado en:
Autores principales: | Li N, Xiong R, He R, Liu B, Wang B, Geng Q |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/65ccaf0097c24bb9a766b278a063020f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
NLRP3 Regulated CXCL12 Expression in Acute Neutrophilic Lung Injury
por: Peng Y, et al.
Publicado: (2020) -
Mangiferin Inhibits Apoptosis and Autophagy Induced by Staphylococcus aureus in RAW264.7 Cells
por: Xu J, et al.
Publicado: (2020) -
New Insights into the Role of NLRP3 Inflammasome in Pathogenesis and Treatment of Chronic Obstructive Pulmonary Disease
por: Zhang J, et al.
Publicado: (2021) -
Spotlight on the NLRP3 inflammasome pathway
por: Groslambert M, et al.
Publicado: (2018) -
Activation and Inhibition of the NLRP3 Inflammasome by RNA Viruses
por: Choudhury SM, et al.
Publicado: (2021)